国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Yersinia pseudotuberculosis serotype IB Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP458451YAW
CSB-EP458451YAW
CSB-BP458451YAW
CSB-MP458451YAW
CSB-EP458451YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Protease HtpX (htpX), partial CSB-YP458452YAW1
CSB-EP458452YAW1
CSB-BP458452YAW1
CSB-MP458452YAW1
CSB-EP458452YAW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Glutamate 5-kinase (proB) CSB-YP458453YAW
CSB-EP458453YAW
CSB-BP458453YAW
CSB-MP458453YAW
CSB-EP458453YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP458454YAW
CSB-EP458454YAW
CSB-BP458454YAW
CSB-MP458454YAW
CSB-EP458454YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Phosphate acyltransferase (plsX) CSB-YP458455YAW
CSB-EP458455YAW
CSB-BP458455YAW
CSB-MP458455YAW
CSB-EP458455YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Cell volume regulation protein A (cvrA), partial CSB-YP458456YAW
CSB-EP458456YAW
CSB-BP458456YAW
CSB-MP458456YAW
CSB-EP458456YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Protein FdhE homolog (fdhE) CSB-YP458457YAW
CSB-EP458457YAW
CSB-BP458457YAW
CSB-MP458457YAW
CSB-EP458457YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB UDP-2,3-diacylglucosamine hydrolase (lpxH) CSB-YP458458YAW
CSB-EP458458YAW
CSB-BP458458YAW
CSB-MP458458YAW
CSB-EP458458YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB o-succinylbenzoate synthase (menC) CSB-YP458459YAW
CSB-EP458459YAW
CSB-BP458459YAW
CSB-MP458459YAW
CSB-EP458459YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB NADH-quinone oxidoreductase subunit C/D (nuoC), partial CSB-YP458460YAW
CSB-EP458460YAW
CSB-BP458460YAW
CSB-MP458460YAW
CSB-EP458460YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB ATP synthase epsilon chain (atpC) CSB-YP458461YAW
CSB-EP458461YAW
CSB-BP458461YAW
CSB-MP458461YAW
CSB-EP458461YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB tRNA modification GTPase MnmE (mnmE) CSB-YP458462YAW
CSB-EP458462YAW
CSB-BP458462YAW
CSB-MP458462YAW
CSB-EP458462YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP458463YAW
CSB-EP458463YAW
CSB-BP458463YAW
CSB-MP458463YAW
CSB-EP458463YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Biotin synthase (bioB) CSB-YP458464YAW
CSB-EP458464YAW
CSB-BP458464YAW
CSB-MP458464YAW
CSB-EP458464YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB UPF0194 membrane protein YPTS_1292 (YPTS_1292) CSB-YP458465YAW
CSB-EP458465YAW
CSB-BP458465YAW
CSB-MP458465YAW
CSB-EP458465YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB UPF0178 protein YPTS_2857 (YPTS_2857) CSB-YP458466YAW
CSB-EP458466YAW
CSB-BP458466YAW
CSB-MP458466YAW
CSB-EP458466YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB UPF0756 membrane protein YPTS_2884 (YPTS_2884), partial CSB-YP458467YAW1
CSB-EP458467YAW1
CSB-BP458467YAW1
CSB-MP458467YAW1
CSB-EP458467YAW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Probable endonuclease 4 (nfo) CSB-YP458468YAW
CSB-EP458468YAW
CSB-BP458468YAW
CSB-MP458468YAW
CSB-EP458468YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP458469YAW
CSB-EP458469YAW
CSB-BP458469YAW
CSB-MP458469YAW
CSB-EP458469YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Deoxyribose-phosphate aldolase (deoC) CSB-YP458470YAW
CSB-EP458470YAW
CSB-BP458470YAW
CSB-MP458470YAW
CSB-EP458470YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>